Oliver Zolk

6.4k citations
109 papers · 4.6k indexed · h-index 42
Topics
Drug Transport and Resistance Mechanisms (23 papers)Receptor Mechanisms and Signaling (16 papers)Renin-Angiotensin System Studies (13 papers)

In The Last Decade

Oliver Zolk

105 papers receiving 4.5k citations

Peers

Oliver Zolk
Comparison fields: 5 of 146
  • Molecular Biology 1.5k
  • Oncology 1.4k
  • Cardiology and Cardiovascular Medicine 1.4k
  • Pediatrics, Perinatology and Child Health 687
  • Surgery 552
Replace Goro Kajiyama with:
Goro Kajiyama Japan
Takashi Izumi Japan
Jing Zhou China
Michael J. Tisdale United Kingdom
Jun Wang China
Gianpiero Pescarmona Italy
John Cijiang He United States
Toshihiko Uematsu Japan
Liberato Berrino Italy
John R. Sedor United States
Oliver Zolk relative to Goro Kajiyama Japan Goro Kajiyama's profile →
Citations per field
00.5×
Goro Kajiyama · 1×
Citations per year

Countries citing papers authored by Oliver Zolk

Since Specialization
Citations

This map shows the geographic impact of Oliver Zolk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Zolk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Zolk more than expected).

Fields of papers citing papers by Oliver Zolk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Zolk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Zolk. The network helps show where Oliver Zolk may publish in the future.

Co-authorship network of co-authors of Oliver Zolk

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Zolk. A scholar is included among the top collaborators of Oliver Zolk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Zolk. Oliver Zolk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 1
5 5
6 3
7 5
8 0
9 51
10 6
11 3
12 65
13 18
14 21
15 27
16 70
17 42
18 47
19 7
20 23

About Oliver Zolk

Oliver Zolk is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Pediatrics, Perinatology and Child Health, having authored 109 papers that have together received 4.6k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (23 papers), Receptor Mechanisms and Signaling (16 papers) and Renin-Angiotensin System Studies (13 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.4k citations), Oncology (1.4k citations) and Pharmacology (345 citations). Oliver Zolk has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Martin F. Fromm, Michael Böhm, Jörg König, Thomas Eschenhagen, Antonio Sarikas, Georg Nickenig, Thorsten Langer, Renke Maas, Pertti J. Neuvonen and Mikko Niemi. Their work appears in journals such as Circulation, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026